HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jihang Yao Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

1/2021OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jihang Yao Research Topics

Disease

5Neoplasms (Cancer)
01/2023 - 03/2016
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 05/2015
2Carcinoma (Carcinomatosis)
01/2023 - 01/2021
2Wounds and Injuries (Trauma)
03/2022 - 01/2021
2Osteosarcoma (Osteogenic Sarcoma)
11/2018 - 10/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
08/2017
1Shock
10/2016
1Carcinogenesis
03/2016
1Paralysis (Palsy)
03/2013
1Brain Ischemia (Cerebral Ischemia)
01/2012
1Ischemia
01/2012

Drug/Important Bio-Agent (IBA)

2HydrogelsIBA
03/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
05/2015 - 01/2012
1triphenylphosphoniumIBA
01/2023
1Mitochondrial DNA (mtDNA)IBA
01/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1imidazoleIBA
01/2023
1Nylons (Nylon)IBA
01/2023
1PyrrolesIBA
01/2023
1Polymethyl Methacrylate (Sol)IBA
03/2022
1Anti-Infective Agents (Microbicides)IBA
03/2022
1Anti-Bacterial Agents (Antibiotics)IBA
03/2022
1Therapeutic UsesIBA
03/2022
1Hemostatics (Antihemorrhagics)IBA
03/2022
1ResveratrolIBA
01/2021
1AlginatesIBA
01/2021
1GelatinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
01/2021
1AldehydesIBA
01/2021
1hydrogen sulfite (bisulfite)IBA
01/2018
1Long Noncoding RNAIBA
01/2018
1B7-H1 AntigenIBA
08/2017
1fluorexon (calcein)IBA
10/2016
1lucifer yellowIBA
10/2016
1Adenosine Triphosphate (ATP)IBA
10/2016
1Coloring Agents (Dyes)IBA
10/2016
1Methotrexate (Mexate)FDA LinkGeneric
10/2016
1Trypan BlueFDA Link
10/2016
1Purinergic P2X7 ReceptorsIBA
10/2016
1Complementary DNA (cDNA)IBA
03/2016
1MicroRNAs (MicroRNA)IBA
03/2016
1Protein AggregatesIBA
01/2012
1salicylhydroxamic acid (SHAM)IBA
01/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2012

Therapy/Procedure

1Injections
03/2022
1Immunotherapy
01/2021
1Combination Drug Therapy (Combination Chemotherapy)
11/2018
1Microspheres (Microsphere)
11/2018
1Drug Therapy (Chemotherapy)
10/2016
1Therapeutics
10/2016
1Cochlear Implants (Cochlear Implant)
03/2013
1Ischemic Postconditioning
01/2012